	US 11,873,298 B2
	Compounds and uses thereof
Matthew Lucas, Lexington, MA (US); Bertrand Le Bourdonnec, Northborough, MA (US); Iwona Wrona, Sharon, MA (US); Bhaumik Pandya, Bedford, MA (US); Parcharee Tivitmahaisoon, Boston, MA (US); Kerem Ozboya, Cambridge, MA (US); Benjamin Vincent, Cambridge, MA (US); Daniel Tardiff, Arlington, MA (US); Jeff Piotrowski, Somerville, MA (US); Eric Solis, Milford, MA (US); Robert Scannevin, Hopkinton, MA (US); Chee-Yeun Chung, Brookline, MA (US); Rebecca Aron, Cambridge, MA (US); and Kenneth Rhodes, Belmont, MA (US)
Assigned to JANSSEN PHARMACEUTICA NV, Beerse (BE)
Appl. No. 16/758,495
Filed by JANSSEN PHARMACEUTICA NV, Beerse (BE)
PCT Filed Oct. 24, 2018, PCT No. PCT/US2018/057339 § 371(c)(1), (2) Date Apr. 23, 2020, PCT Pub. No. WO2019/084157, PCT Pub. Date May 2, 2019.
Claims priority of provisional application 62/662,424, filed on Apr. 25, 2018.
Claims priority of provisional application 62/576,591, filed on Oct. 24, 2017.
Prior Publication US 2020/0262828 A1, Aug. 20, 2020
Int. Cl. C07D 413/14 (2006.01); C07D 271/07 (2006.01); C07D 413/04 (2006.01); C07D 413/10 (2006.01); C07D 417/04 (2006.01); C07D 417/14 (2006.01); C07D 471/04 (2006.01); C07D 487/04 (2006.01); C07D 487/10 (2006.01)

CPC C07D 413/14 (2013.01) [C07D 271/07 (2013.01); C07D 413/04 (2013.01); C07D 413/10 (2013.01); C07D 417/04 (2013.01); C07D 417/14 (2013.01); C07D 471/04 (2013.01); C07D 487/04 (2013.01); C07D 487/10 (2013.01)]

8 Claims

1. A compound, or pharmaceutically acceptable salt thereof, having the structure of any one of the following compounds:


	#	Structure

	1241

	1238

	1237

	1236

	1232

	1231

	1228

	1227

	1226

	1225

	1110

	1111